0 Grace A Posted July 11, 2019 Author Share Posted July 11, 2019 Quote Link to comment Share on other sites More sharing options...
0 Ignatius Bose Posted July 11, 2019 Share Posted July 11, 2019 Shares of Gerresheimer AG (ETR:GXI) are soaring by more than 8% on Thursday after the German pharmaceutical packaging firm reported more than a 140% surge in net income for the second quarter and reiterated its full-year revenue guidance. Gerresheimer, the German-based manufacturer of primary packaging products for medication reported a net profit of €47.1m for the three months to 31st May compared with €19.3m in the previous year. Likewise, the quarterly earnings before interest, taxes, depreciation and amortisation (EBITDA) surged by 38% to €99.4m while revenues rose 7.2% to €356.5m respectively. Gerresheimer maintained its revenue outlook of €1.40-1.45bn for full-year 2019 while it anticipated adjusted EBITDA to come in at around €295m, +/- €5m, excluding the €118.5m already accounted for from the acquisition of Sensile Medical. At 12.30pm GMT on Thursday, shares of Gerresheimer were trading at €70.65, soaring 8.61% for the session. The company’s stock has had a rollicking year with prices jumping more than 23% YTD compared to the 17% gains on the DAX 30. Quote Link to comment Share on other sites More sharing options...
Question
Grace A
Link to comment
Share on other sites
1 answer to this question
Recommended Posts
Join the conversation
You can post now and register later. To reply to this question, sign in or create a new account.